These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 24626572)

  • 21. Changes in the proportions of CD4(+)T cell subsets defined by CD127 and CD25 expression during HBV infection.
    Xu HT; Ye J; Chen YB; Zhang LX; Huang JX; Xian JC; Liu L; Peng HL; Li L; Lin M; Huang JH
    Immunol Invest; 2012; 41(3):290-303. PubMed ID: 22122423
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulatory T-cell responses in chronic hepatitis B patients treated with nucleos(t)ide analogs compared with healthy subjects and untreated infected individuals.
    Chen LY; Zhu LY; Yang BS; Bi MR; Yan BZ; Wang W; Ma YJ
    Hepatogastroenterology; 2012; 59(120):2582-6. PubMed ID: 22626879
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intrahepatic regulatory T cells are phenotypically distinct from their peripheral counterparts in chronic HBV patients.
    Stoop JN; Claassen MA; Woltman AM; Binda RS; Kuipers EJ; Janssen HL; van der Molen RG; Boonstra A
    Clin Immunol; 2008 Dec; 129(3):419-27. PubMed ID: 18823821
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of SATB1 expression in regulatory T cells contributes to hepatitis B virus-related chronic liver inflammation.
    Li XF; Tian L; Wang YY; Kong HS; Dong YJ; Zhu QY; Ni Q; Chen Y
    Mol Med Rep; 2015 Jan; 11(1):231-6. PubMed ID: 25338958
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changes of regulatory T cells and FoxP3 gene expression in the aging process and its relationship with lung tumors in humans and mice.
    Pan XD; Mao YQ; Zhu LJ; Li J; Xie Y; Wang L; Zhang GB
    Chin Med J (Engl); 2012 Jun; 125(11):2004-11. PubMed ID: 22884069
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circulating CD4+ CD25+ regulatory T cells correlate with chronic hepatitis B infection.
    Peng G; Li S; Wu W; Sun Z; Chen Y; Chen Z
    Immunology; 2008 Jan; 123(1):57-65. PubMed ID: 17764450
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of telbivudine therapy on the cellular immune response in chronic hepatitis B.
    Chen Y; Li X; Ye B; Yang X; Wu W; Chen B; Pan X; Cao H; Li L
    Antiviral Res; 2011 Jul; 91(1):23-31. PubMed ID: 21549152
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dissection of a circulating and intrahepatic CD4(+)Foxp3(+) T-cell subpopulation in chronic hepatitis B virus (HBV) infection: a highly informative strategy for distinguishing chronic HBV infection states.
    Zhang M; Zhou J; Zhao T; Huang G; Tan Y; Tan S; Fu X; Niu W; Meng G; Chen X; Shang X; Liu D; Ni B; Wang L; Wu Y
    J Infect Dis; 2012 Apr; 205(7):1111-20. PubMed ID: 22357657
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IL-35 expression in peripheral blood CD4(+) T cells from chronic hepatitis B virus-infected patients directly correlates with virus load.
    Zhou Y; Zhang H; Li Y
    Cytokine; 2015 May; 73(1):169-75. PubMed ID: 25752977
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased CD4+CD25+ regulatory T cells correlate with poor short-term outcomes in hepatitis B virus-related acute-on-chronic liver failure patients.
    Shen C; Yan WZ; Zhao CY; Che HH; Liu XY; Liu ZZ; Wang YD; Wang W; Li M; Gao J
    J Microbiol Immunol Infect; 2015 Apr; 48(2):137-46. PubMed ID: 24388581
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The frequency and skewed T-cell receptor beta-chain variable patterns of peripheral CD4(+)CD25(+) regulatory T-cells are associated with hepatitis B e antigen seroconversion of chronic hepatitis B patients during antiviral treatment.
    Yang J; Sheng G; Xiao D; Shi H; Wu W; Lu H; Cao H; Li L
    Cell Mol Immunol; 2016 Sep; 13(5):678-87. PubMed ID: 26899927
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interleukin-35 Suppresses Antiviral Immune Response in Chronic Hepatitis B Virus Infection.
    Shao X; Ma J; Jia S; Yang L; Wang W; Jin Z
    Front Cell Infect Microbiol; 2017; 7():472. PubMed ID: 29181338
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD4+Foxp3+ regulatory T cells converted by rapamycin from peripheral CD4+CD25(-) naive T cells display more potent regulatory ability in vitro.
    Chen JF; Gao J; Zhang D; Wang ZH; Zhu JY
    Chin Med J (Engl); 2010 Apr; 123(7):942-8. PubMed ID: 20497692
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Myeloid-derived suppressor cells induce regulatory T cells in chronically HBV infected patients with high levels of hepatitis B surface antigen and persist after antiviral therapy.
    Pal S; Nandi M; Dey D; Chakraborty BC; Shil A; Ghosh S; Banerjee S; Santra A; Ahammed SKM; Chowdhury A; Datta S
    Aliment Pharmacol Ther; 2019 May; 49(10):1346-1359. PubMed ID: 30982998
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients.
    Fu J; Xu D; Liu Z; Shi M; Zhao P; Fu B; Zhang Z; Yang H; Zhang H; Zhou C; Yao J; Jin L; Wang H; Yang Y; Fu YX; Wang FS
    Gastroenterology; 2007 Jun; 132(7):2328-39. PubMed ID: 17570208
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recovery of circulating CD56
    Liu N; Liu B; Zhang L; Li H; Chen Z; Luo A; Chen M; Peng M; Yin W; Ren H; Hu P
    Int Immunopharmacol; 2018 Sep; 62():59-66. PubMed ID: 29990695
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression patterns of HLA-DR+ or HLA-DR- on CD4+/CD25++/CD127low regulatory T cells in patients with allergy.
    Geraldes L; Morgado J; Almeida A; Todo-Bom A; Santos P; Paiva A; Cheira C; Pais ML
    J Investig Allergol Clin Immunol; 2010; 20(3):201-9. PubMed ID: 20635785
    [TBL] [Abstract][Full Text] [Related]  

  • 38. FoxP3+ CD25+ CD8+ T-cell induction during primary simian immunodeficiency virus infection in cynomolgus macaques correlates with low CD4+ T-cell activation and high viral load.
    Karlsson I; Malleret B; Brochard P; Delache B; Calvo J; Le Grand R; Vaslin B
    J Virol; 2007 Dec; 81(24):13444-55. PubMed ID: 17898053
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A possible role for NKT-like cells in patients with chronic hepatitis B during telbivudine treatment.
    Diao H; He J; Zheng Q; Chen J; Cui G; Wei Y; Ye P; Kohanawa M; Li L
    Immunol Lett; 2014 Jul; 160(1):65-71. PubMed ID: 24718278
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TCRγδ(+)CD4(-)CD8(-) T cells suppress the CD8(+) T-cell response to hepatitis B virus peptides, and are associated with viral control in chronic hepatitis B.
    Lai Q; Ma S; Ge J; Huang Z; Huang X; Jiang X; Li Y; Zhang M; Zhang X; Sun J; Abbott WG; Hou J
    PLoS One; 2014; 9(2):e88475. PubMed ID: 24551107
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.